Geriatric Assessment and Intervention for Older Patients With Frailty in the Emergency Department

NCT03751319 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 432

Last updated 2021-08-11

No results posted yet for this study

Summary

Comprehensive Geriatric Assessment (CGA) is an established approach for better detection of frailty-related problems and includes individualized treatment plan with multi-discipline supportive and treating measures for the older frailty patients. However, there is limited evidence of feasibility and efficacy of the CGA when provided in the emergency department setting.

In the GAOPS-study the efficacy of the CGA in emergency department setting will be studied by randomized controlled study protocol. We aim to study if the CGA provided in the ED is feasible, safe and efficient method when added with standard emergency care for older frail patients.

Conditions

  • Frail Elderly Syndrome
  • Patient Admission
  • Hospital Readmission
  • Length of Stay
  • Fall
  • Quality of Life

Interventions

OTHER

CGA

Comprehensive Geriatric Assessment

Sponsors & Collaborators

  • City of Espoo

    collaborator UNKNOWN
  • University of Helsinki

    collaborator OTHER
  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Veli-Pekka Harjola · Department of Emergency Medicine and Services, Helsinki University Hospital

  • Janne Alakare, MD · Department of Emergency Medicine and Services, Helsinki University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-11
Primary Completion
2020-06-07
Completion
2021-07-02

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03751319 on ClinicalTrials.gov